Opposing effects of CCKA and CCKB antagonists on the development of conditioned activity in rats

Behavioural Pharmacology

Volumn 7, Issue 6, 1996, Pages 505-512

  Josselyn, S A ^a   Vaccarino, F J ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Cholecystokinin; Conditioned activity; Devazepide; L 365,260; Locomotion; Rat

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; DEVAZEPIDE;

ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; DRUG ANTAGONISM; ENVIRONMENTAL FACTOR; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; NONHUMAN; RAT;

EID: 0030459052     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Beninger RJ and Hahn BL (1983) Pimozide blocks establishment but not expression of amphetamine-produced environment-specific conditioning. Science, 220, 1304-1306.
2. Beninger RJ and Herz RS (1986) Pimozide blocks establishment but not expression of cocaine-produced environment-specific conditioning. Life Sciences, 38, 1425-1431.
3. Blackburn JR, Phillips AG, Jakubovic A and Fibiger HC (1989) Dopamine and preparatory behavior: II. A new analysis. Behavioural Neuroscience, 103, 15-23.
4. Bozarth MA and Wise RA (1981) Heroin reward is dependent on a dopaminergic substrate. Life Sciences, 29, 1881-1886.
5. Carboni E, Imperato A, Perezzani L and Di Chiara G (1989) Amphetamine, cocaine, phencyclidine increase extracellular dopamine concentration preferentially in the nucleus accumbens of freely moving rat.Neuroscience, 28, 653-661.
6. Chang RSL and Lotti VJ (1986) Biochemical and pharmacological characterization of an extremely potent and selective non-peptide CCK antagonist. Proceedings of the National Academy of Sciences USA, 83, 4923-5926.
7. B) and gastrin receptor radioligand. Molecular Pharmacology, 35, 803-909.
8. Crawley JN (1992) Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway. Journal of Neuroscience, 12, 3380-3393.
9. de Weerth A, Pisegna JR, Huppi K and Wank SA (1993) Molecular cloning, functional expression and chromosomal localization of the human cholecystokinin type A receptor. Biochemical and Biophysical Research Communications, 194, 811-818.
10. DiChiara G and Imperato A (1988) Drugs abused by humans preferentially increase synaptic concentration of dopamine in the mesolimbic system of freely moving rats. Proceedings of the National Academy of Sciences USA, 85, 5274-5278.
11. Dourish CT, Hawley D and Iversen SD (1988) Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718. European Journal of Pharmacology, 147, 469-472.
12. B receptor. European Journal of Pharmacology, 176, 35-44.
13. Drew KL and Glick SD (1990) Role of D-1 and D-2 receptor stimulation in sensitization to amphetamine-induced circling behavior and in expression and extinction of the Pavlovian conditioned response. Psychopharmacology, 101, 465-471.
14. Fontana D, Post RM, Weiss SRB and Pert A (1993) The role of D1 and D2 dopamine receptors in the acquisition and expression of cocaine-induced conditioned increases in locomotor behavior.Behavioural Pharmacology, 4, 375-387.
15. Harro J and Vasar E (1991) Cholecystokinin-induced anxiety: how is it reflected in studies on exploratory behavior. Neuroscience and Biobehavioral Reviews, 15, 473-477.
16. A receptor antagonist devazepide. European Journal of Pharmacology, 197, 229-230.
17. B receptor antagonists. Brain Research, 572, 208-215.
18. B receptor mechanisms to individual differences in amphetamine-induced locomotion. Pharmacology, Biochemistry and Behavior, 48, 1019-1024.
19. Hokfelt T, Rehfeld JF, Skirboll L, Ivemark B, Goldstein M and Markey K (1980) Evidence of co-existence of dopamine and CCK in meso-limbic neurons. Nature, 285 476-478.
20. Innis RB and Snyder SH (1980) Distinct cholecystokinin receptors in brain and pancreas. Proceedings of the National Academy of Sciences USA, 77, 6917-6921.
21. Jones GH and Robbins TW (1992) Differential effects of mesocortical, mesolimbic, and mesostriatal dopamine depletion on spontaneous, conditioned and drug-induced locomotor activity. Pharmacology, Biochemistry and Behavior, 43, 887-895.
22. A antagonist, impairs the acquisition of conditioned reward and conditioned activity. Psychopharmacology, 123, 131-143.
23. Keppel G (1982). Design and Analysis: A Researcher's Handbook, 2nd edn. Prentice-Hall, Inc., Englewood Cliffs, NJ.
24. Lemaire M, Piot O, Roques BP, Bohme GA and Blanchard JC (1992) Evidence for an endogenous cholecystokininergic balance in social memory. Neuroreport, 3, 929-932.
25. B receptor agonists and antagonists modulate olfactory recognition in male rats. Psychopharmacology, 115, 435-440.
26. Mackey WB and van der Kooy D (1985) Neuroleptics block the positive reinforcing effects of amphetamine but not of morphine as measured by place conditioning. Pharmacology, Biochemistry and Behavior 22, 101-105.
27. B receptors in behavioral and hormonal studies in rats. Naunyn-Schmiedeberg's Archives of Pharmacology, 349, 478-484.
28. Marshall FH, Barnes S, Hughes J, Woodruff GN and Hunter JC (1991) Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms. Journal of Neurochemistry, 56, 917-922.
29. Mazurski EJ and Beninger RJ (1987) Environment-specific conditioning and sensitization with (+)-amphetamine. Pharmacology, Biochemistry and Behavior, 27, 61-65.
30. Mazurski EJ and Beninger RJ (1991) Effects of selective drugs for dopaminergic D1 and D2 receptors on conditioned locomotion in rats. Psychopharmacology, 105, 107-112.
31. Post RM, Lockfeld A, Squillace KM and Contel NR (1981) Drug-environment interaction: context-dependency of cocaine-induced behavioral sensitization. Life Sciences, 28, 755-760.
32. Reimer AR and Martin-Iverson MT (1994) Nimodipine and haloperidol attenuate behavioral sensitization to cocaine but only nimodipine blocks the establishment of conditioned locomotion induced by cocaine. Psychopharmacology, 113, 404-410.
33. Sankaran H, Goldfine ID, Deveney CW, Wong KW and Williams JA (1980) Binding of cholecystokinin to high affinity receptors on isolated pancreatic acini. Journal of Biological Chemistry, 255, 18,849-18,853.
34. Spyraki C, Fibiger HC and Phillips AG (1982a) Dopaminergic substrates of amphetamine-induced place preference conditioning. Brain Research, 253, 185-193.
35. Spyraki C, Fibiger HC and Phillips AG (1982b) Attenuation by haloperidol of place preference conditioning using food reward. Psychopharmacology, 77, 379-382.
36. Studier JM, Reibaud M, Herve D, Blanc G and Tassin JP (1986) Opposite effects of sulfated CCK on dopamine-sensitive adenylate cyclase in two areas of the rat nucleus accumbens. European Journal of Pharmacology, 126, 155-158.
37. Vaccarino FJ (1994) Nucleus accumbens dopamine-CCK interactions in psychostimulant reward and related behaviors. Neuroscience and Biobehavioral Reviews, 18, 207-214.
38. Vanderhaegan JJ, Signeau JC and Gepts W (1975) New peptide in the vertebrate CNS reacting with antigastrin antibodies. Nature, 257, 604-605.
39. Vezina P and Stewart J (1987) Conditioned locomotion and place preference elicited by tactile cue paired exclusively with morphine in an open field. Psychopharmacology, 91, 375-380.
40. Vickroy TW, Bianchi BR, Kerwin JF Jr, Kopecka H and Hadzan AM (1988) Evidence that type A CCK receptors facilitate dopamine efflux in rat brain. European Journal of Pharmacology, 152, 371-372.
41. Wang RY and Hu XT (1986) Does CCK potentiate dopamine action in the nucleus accumbens? Brain Research, 380, 363-367.
42. Wang RY and White FJ (1985) Electrophysiological effects of CCK: central dopaminergic systems. Progress in Clinical and Biological Research, 192, 95-103.
43. Wank SA, Pisegna JR and de Weerth A (1992) Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression. Proceedings of the National Academy of Sciences USA, 89, 8670-8691.